These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34692498)

  • 41. Gene expression profiles help identify the tissue of origin for metastatic brain cancers.
    Wu AH; Drees JC; Wang H; VandenBerg SR; Lal A; Henner WD; Pillai R
    Diagn Pathol; 2010 Apr; 5():26. PubMed ID: 20420692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and immune profiling for cancer of unknown primary site.
    Haratani K; Hayashi H; Takahama T; Nakamura Y; Tomida S; Yoshida T; Chiba Y; Sawada T; Sakai K; Fujita Y; Togashi Y; Tanizaki J; Kawakami H; Ito A; Nishio K; Nakagawa K
    J Immunother Cancer; 2019 Sep; 7(1):251. PubMed ID: 31519206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying cancer tissue-of-origin by a novel machine learning method based on expression quantitative trait loci.
    Miao Y; Zhang X; Chen S; Zhou W; Xu D; Shi X; Li J; Tu J; Yuan X; Lv K; Tian G
    Front Oncol; 2022; 12():946552. PubMed ID: 36016607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
    Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
    BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction.
    Greco FA; Spigel DR; Yardley DA; Erlander MG; Ma XJ; Hainsworth JD
    Oncologist; 2010; 15(5):500-6. PubMed ID: 20427384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer.
    Kurahashi I; Fujita Y; Arao T; Kurata T; Koh Y; Sakai K; Matsumoto K; Tanioka M; Takeda K; Takiguchi Y; Yamamoto N; Tsuya A; Matsubara N; Mukai H; Minami H; Chayahara N; Yamanaka Y; Miwa K; Takahashi S; Takahashi S; Nakagawa K; Nishio K
    PLoS One; 2013; 8(5):e63249. PubMed ID: 23671674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
    Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
    BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with
    Gröschel S; Bommer M; Hutter B; Budczies J; Bonekamp D; Heining C; Horak P; Fröhlich M; Uhrig S; Hübschmann D; Geörg C; Richter D; Pfarr N; Pfütze K; Wolf S; Schirmacher P; Jäger D; von Kalle C; Brors B; Glimm H; Weichert W; Stenzinger A; Fröhling S
    Cold Spring Harb Mol Case Stud; 2016 Nov; 2(6):a001180. PubMed ID: 27900363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review.
    Lombardo R; Tosi F; Nocerino A; Bencardino K; Gambi V; Ricotta R; Spina F; Siena S; Sartore-Bianchi A
    Front Oncol; 2020; 10():533. PubMed ID: 32457826
    [No Abstract]   [Full Text] [Related]  

  • 50. "Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"?
    Kolling S; Ventre F; Geuna E; Milan M; Pisacane A; Boccaccio C; Sapino A; Montemurro F
    Front Oncol; 2019; 9():1546. PubMed ID: 32010631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer of unknown primary site: missing primary or missing biology?
    Pentheroudakis G; Briasoulis E; Pavlidis N
    Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
    Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
    Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A second-generation microRNA-based assay for diagnosing tumor tissue origin.
    Meiri E; Mueller WC; Rosenwald S; Zepeniuk M; Klinke E; Edmonston TB; Werner M; Lass U; Barshack I; Feinmesser M; Huszar M; Fogt F; Ashkenazi K; Sanden M; Goren E; Dromi N; Zion O; Burnstein I; Chajut A; Spector Y; Aharonov R
    Oncologist; 2012; 17(6):801-12. PubMed ID: 22618571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
    Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
    Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [CUP syndrome: are there advances?].
    Moll R
    Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy.
    Gatalica Z; Xiu J; Swensen J; Vranic S
    Eur J Cancer; 2018 May; 94():179-186. PubMed ID: 29571084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.
    Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA
    Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene-expression assays and personalized cancer care: tissue-of-origin test for cancer of unknown primary origin.
    Takei H; Monzon FA
    Per Med; 2011 Jul; 8(4):429-436. PubMed ID: 29783334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene Expression Profiling for Differential Diagnosis of Liver Metastases: A Multicenter, Retrospective Cohort Study.
    Wang Q; Li F; Jiang Q; Sun Y; Liao Q; An H; Li Y; Li Z; Fan L; Guo F; Xu Q; Wo Y; Ren W; Yue J; Meng B; Liu W; Zhou X
    Front Oncol; 2021; 11():725988. PubMed ID: 34631555
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.